Advances in Therapy

, Volume 27, Issue 6, pp 321–333 | Cite as

Engaging and empowering patients to manage their type 2 diabetes, Part I: a knowledge, attitude, and practice gap?

  • Manuel Serrano-Gil
  • Stephan Jacob


For over 20 years, the World Health Assembly has recognized diabetes (type 1 and type 2) as a serious threat to national health and economic development and called for action regarding its prevention and control. However, the prevalence of type 2 diabetes continues to rise despite a significant percentage of cases being preventable. Furthermore, data suggest that in many patients diagnosed with type 2 diabetes, glycated hemoglobin (HbA1c) levels remain above the agreed international and national target levels, despite the availability of numerous antihyperglycemic agents, the best intentions of both patient and physician, and the support of the wider healthcare team. Part I of this two-part review considers evidence that seems to suggest there is a knowledge, attitude, and practice (KAP) gap in type 2 diabetes, and that although theoretical knowledge of how type 2 diabetes should be managed exists, the attitude of patients and healthcare professionals may influence the practicalities of implementing life-enhancing changes for patients living day-to-day with the condition. Here, we consider why there may be a KAP gap, how type 2 diabetes is currently being assessed and managed, and whether these current management approaches remain valid in the light of recent studies evaluating the impact of lowering current target HbA1c levels. This article also explores how encouraging patients to self-manage their disease, as well as engaging all stakeholders in the necessary behavioral changes, can positively influence the long-term treatment outcomes of patients with type 2 diabetes.


ant ihyperglycemic agents cardiovascular risk diabetes management glycemic control patient engagement type 2 diabetes 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    World Health Organization web site. WHA42.36. Prevention and control of diabetes mellitus. May 18–19, 1989. Available at: Accessed Februrary 24, 2010.
  2. 2.
    United Nations web site. UN Resolution 61/225. United Nations General Assembly 61st session, December 2006. Available at: Accessed February 24, 2010.
  3. 3.
    IDF Diabetes Atlas, 4th edition. International Diabetes Federation; 2009. Available at: Accessed February 24, 2010.
  4. 4.
    Mybanya JC. Activity report 2006/2009. International Diabetes Federation; 2009. Available at: Accessed February 24, 2010.
  5. 5.
    Kraushaar LE, Krämer A. Are we losing the battle against cardiometabolic disease? The case for a paradigm shift in primary prevention. BMC Public Health. 2009;9:64–72.CrossRefPubMedGoogle Scholar
  6. 6.
    Benhalima K, Mathieu C. Challenges in the management of hyperglycaemia in type 2 diabetes. Background paper in IDF Diabetes Atlas, 4th edition. International Diabetes Federation; 2009. Available at: Diabetes_0.pdf. Accessed February 24, 2010.
  7. 7.
    Chan JC, Gagliardino JJ, Baik SH, et al. IDMPS Investigators. Multifaceted determinants for achieving glycemic control: the International Diabetes Management Practice Study (IDMPS). Diabetes Care. 2009;32:227–233.CrossRefPubMedGoogle Scholar
  8. 8.
    Nathan DM, Buse JB, Davidson MB, et al. American Diabetes Association; European Association for Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32:193–203.CrossRefPubMedGoogle Scholar
  9. 9.
    Monnier L, Colette C, Owens DR. Type 2 diabetes: a well-characterised but suboptimally controlled disease. Can we bridge the divide? Diabetes Metab. 2008;34:207–216.CrossRefPubMedGoogle Scholar
  10. 10.
    Graham I, Atar D, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Eur Heart J. 2007;28:2375–2414.CrossRefPubMedGoogle Scholar
  11. 11.
    DIABESITY. Novel molecular targets for obesity and type 2 diabetes. A European Union Framework Programme VI Integrated Project. Available at: Accessed February 14, 2010.
  12. 12.
    International Chair on Cardiometabolic Risk. The obesity and type 2 diabetes epidemics. Available at: Accessed March 13, 2010.
  13. 13.
    Hinnen D, Nielsen LL, Waninger A, Kushner P. Incretin mimetics and DDP-IV inhibitors: new paradigms for the treatment of type 2 diabetes. J Am Board Fam Med. 2006;19:612–620.CrossRefPubMedGoogle Scholar
  14. 14.
    Woo V, Shestakova MV, Örskov C, Ceriello A. Targets and tactics: the relative importance of HbA1c, fasting and postprandial plasma glucose control levels to glycaemic control in type 2 diabetes. Int J Clin Pract. 2008;62:1935–1942.CrossRefPubMedGoogle Scholar
  15. 15.
    Gerstein HC, Miller ME, Byington RP, et al.; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–2559.CrossRefPubMedGoogle Scholar
  16. 16.
    Duckworth W, Abraira C, Moritz T, et al. VADT Investigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–139.CrossRefPubMedGoogle Scholar
  17. 17.
    Currie CJ, Peters JR, Tynan A, et al. Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study. Lancet. 2010;375:481–489.CrossRefPubMedGoogle Scholar
  18. 18.
    Sevick MA, Trauth JM, Ling BS, et al. Patients with complex chronic diseases: perspectives on supporting self-management. J Gen Intern Med. 2007;22(suppl. 3):438–444.CrossRefGoogle Scholar
  19. 19.
    International Diabetes Federation web site. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. 2006. Available at: Last accessed April 1, 2010.
  20. 20.
    Nalysnyk L, Hernandex-Medina M, Krishnarajah G. Glycemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12:288–298.CrossRefPubMedGoogle Scholar
  21. 21.
    Gandhi GY, Murad MH, Fujiyoshi A, et al. Patient-important outcomes in registered diabetes trials. JAMA. 2008;299:2543–2549.CrossRefPubMedGoogle Scholar
  22. 22.
    Shaughnessy AF, Slawson DC. What happened to the valid POEMs? A survey of review articles on the treatment of type 2 diabetes. BMJ. 2003;327:266.CrossRefPubMedGoogle Scholar
  23. 23.
    Anderson RM, Fitzgerald JT, Funnell MM, Marrero DG. The Diabetes Empowerment scale. A measure of psychosocial self efficacy. Diabetes Care. 2000;23:739–743.CrossRefPubMedGoogle Scholar
  24. 24.
    Schmittdiel J, Mosen DM, Glasgow RE, Hibbard J, Remmers C, Bellows J. Patient assessment of chronic illness care (PACIC) and improved patient-centred outcomes for chronic conditions. J Gen Inter Med. 2007;23:77–80.CrossRefGoogle Scholar
  25. 25.
    Glasgow RE, Peeples M, Skovlund SE. Where is the patient in diabetes performance measures? The case for including patient-centered and self-management measures. Diabetes Care. 2008;31:1046–1050.CrossRefPubMedGoogle Scholar
  26. 26.
    Kaiser Pemanente Colorado Region. web site. Available at: Accessed March 13, 2010.
  27. 27.
    Hesler M, Kieffer E, Pietted JD, Vijan S, Spencer M. The relationship between knowledge of recent HbA1c values and diabetes care understanding and self management. Diabetes Care. 2005;28:816–822.CrossRefGoogle Scholar
  28. 28.
    Klonoff DC. Benefits and limitations of self-monitoring of blood glucose. J Diabetes Sci Technol. 2007;1:130–132.PubMedGoogle Scholar
  29. 29.
    Farmer AJ, Wade AN, French DP, et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol Assess. 2009;13:1–72.Google Scholar
  30. 30.
    NHS Diabetes. Self-monitoring of blood glucose in non-insulin treated type 2 diabetics. A report prepared by an NHS Diabetes Working Group. NHS Diabetes March 2010 Diabetes 129. Available at: Accessed February 24, 2010.
  31. 31.
    International Diabetes Foundation web site. Choosing to take control in type 2 diabetes. April 2007. Available at: Accessed April 1, 2010.
  32. 32.
    Peyrot M, Matthews DR, Rubin RR, et al. Resistance to insulin therapy among patients and providers. Results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care. 2005;28:2673–2679.CrossRefPubMedGoogle Scholar
  33. 33.
    Anderson RM, Funnell MM. Using the empowerment approach to help patients change behaviour. In: Anderson BJ, Rubin RR, eds. Practical psychology for diabetes clinicians. 2nd Edition. Alexandria: American Diabetes Association; 2002.Google Scholar
  34. 34.
    Institute of Medicine, Committee on Quality of Health Care in America. Crossing the Quality Chasm. A New Health System for the 21st Century. Washington: National Academic Press; 2001.Google Scholar
  35. 35.
    The King’s Fund web site. Patient-centred care. The King’s Fund March 2009. Available at: Accessed February 24, 2010.
  36. 36.
    Wagner EH. Chronic disease management: what will it take to improve care for chronic illness? Eff Clin Practice. 1998;1:2–4.Google Scholar
  37. 37.
    Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff. 2001;20:64–78.CrossRefGoogle Scholar
  38. 38.
    Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff. 2009;28:75–85.CrossRefGoogle Scholar
  39. 39.
    Bodenheimer T, Wagner EH, Grumbach K. Improving primary care for patients with chronic illness. JAMA. 2002;288:1909–1914.CrossRefPubMedGoogle Scholar
  40. 40.
    World Health Organization web site. The Innovative Care for Chronic Conditions framework (ICCC). WHO 2010. Available at: Accessed February 24, 2010.
  41. 41.
    World Health Organization web site. Diabetes Action Online Overview. WHO 2010. Available at: Accessed March 13, 2010.
  42. 42.
    Simmons RK, Unwin N, Griffin SJ. International Diabetes Federation: an update of the evidence concerning the prevention of type 2 diabetes. Background paper in IDF Diabetes Atlas, 4th edition. International Diabetes Federation; 2009. Available at: Accessed April 1, 2010.
  43. 43.
    Trento M, Tomelini M, Basile M, et al. The locus of control in patients with type 1 and type 2 diabetes managed by individual and group care. Diabet Med. 2008;25:86–90.PubMedGoogle Scholar
  44. 44.
    Furler J, Walker C, Blackberry I, et al. The emotional context of self management in chronic illness: a qualitative study of the role of health professional support in the self-management of type 2 diabetes. BMC Health Services Research. 2008;8:214–222.CrossRefPubMedGoogle Scholar
  45. 45.
    International Diabetes Federation web site. International standards for diabetes education. 3rd edition. International Diabetes Federation 2009. Available at: Accessed February 24, 2010.
  46. 46.
    Berwick DM. Lessons from developing nations on improving health care. BMJ. 2004;328:1124–1129.CrossRefPubMedGoogle Scholar
  47. 47.
    American Association of Diabetes Educators AADE7™ Measurable behaviour change is the desired outcome of diabetes education. Available at: Accessed February 24, 2010.
  48. 48.
    Lawson VL, Bundy C, Harvey JN. The development of personal models of diabetes in the first 2 years after diagnosis: a prospective longitudinal study. Diabet Med. 2008;25:482–490.CrossRefPubMedGoogle Scholar
  49. 49.
    Gensichen J, Von Korff M, Rutter CM, et al. Physician support for diabetes patients and clinical outcomes. BMC Public Health. 2009;9:367.CrossRefPubMedGoogle Scholar
  50. 50.
    Hojat M, Gonnella JS, Nasca TJ, Mangione S, Vergare M, Magee M. Physician empathy: definition, components, measurement, and relationship to gender and specialty. Am J Psychiatry. 2002;159:1563–1569.CrossRefPubMedGoogle Scholar
  51. 51.
    Angelmar R, Berman PC. Patient empowerment and efficient health outcomes. Report 3 from Sustainable Healthcare Financing: new approaches for new outcomes conference, Helsinki February 2007. Available at: Accessed February 24, 2010.
  52. 52.
    Boren SA. A review of health literacy and diabetes: opportunities for technology. J Diabetes Sci Technol. 2009;3:202–209.PubMedGoogle Scholar
  53. 53.
    Cavanaugh K, Hulzinga MM, Wallston KA, et al. Association of numeracy and diabetes control. Ann Intern Med. 2008;148:737–746.PubMedGoogle Scholar
  54. 54.
    Kutner M, Greenberg E, Jin Y, Paulsen C. The health literacy of America’s adults: results from the 2003 National Assessment of Adult Literacy (NCES 2006-483). US Department of Education. Washington, DC: National Center for Education Statistics; 2006Google Scholar
  55. 55.
    Schillinger D, Grumbach K, Piette J, et al. Association of health literacy with diabetes outcomes. JAMA. 2002;288:475–482.CrossRefPubMedGoogle Scholar
  56. 56.
    Bodenheimer T, Lorig K, Holman H, Grumbach K. Patient self-management of chronic disease in primary care. JAMA. 2002;288:2469–2475.CrossRefPubMedGoogle Scholar
  57. 57.
    Schillinger D, Piette J, Grumbach K, et al. Closing the loop. Arch Intern Med. 2003;163:83–90.CrossRefPubMedGoogle Scholar
  58. 58.
    Geiss LS, James C, Gregg EW, Albright A, Williamson DF, Cowie CC. Diabetes risk reduction behaviors among U.S. adults with prediabetes. Am J Prev Med. 2010;38:403–409.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Healthcare 2010

Authors and Affiliations

  1. 1.Fundacion Educacion Salud y SociedadMurciaSpain
  2. 2.Cardio-metabolic InstituteVillingen-SchwenningenGermany

Personalised recommendations